🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.

Several experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the service has removed problematic content and banned associated keywords and search suggestions. The company stated it was committed to maintaining the platform safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with images of weight loss, glowing testimonials and detailed instructions for preparing or administering at home.

Within moments of joining one group, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Within these communities, posts display black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Although the science behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially serious health risks”.